Serum osteopontin levels in patients with acute liver dysfunction

References

• Okuda K, Mitchell DG, Itai Y, Ariyama J. Hepatobiliary diseases: pathophysiology and imaging. Blackwell Science, OxfordUK 2001; 93–102
   Google Scholar
• Riordan SM, Williams R. Fulminant hepatic failure. Clin Liver Dis 2000; 4: 25–45
   PubMedGoogle Scholar
• Farmer, DG, Anselmo, DM, Ghobrial, RM, Yersiz, H, McDiarmid, SV,Cao, C, et al., Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg 2003;237:666–75; discussion 675–66.
   PubMedGoogle Scholar
• Hoofnagle JH, Carithers RL, Jr., Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995; 21: 240–52
   PubMed Web of Science ®Google Scholar
• Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003; 125: 755–64
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60–6
   PubMed Web of Science ®Google Scholar
• Alison MR, Poulsom R, Forbes SJ. Update on hepatic stem cells. Liver 2001; 21: 367–73
   PubMedGoogle Scholar
• Zimmermann A. Liver regeneration: the emergence of new pathways. Med Sci Monit ;:R 2002; 8: A53–63
   Google Scholar
• Haque S, Haruna Y, Saito K, Nalesnik MA, Atillasoy E, Thung SN, et al. Identification of bipotential progenitor cells in human liver regeneration. Lab Invest 1996; 75: 699–705
   PubMedGoogle Scholar
• Arai M, Yokosuka O, Fukai K, Imazeki F, Chiba T, Sumi H, et al. Gene expression profiles in liver regeneration with oval cell induction. Biochem Biophys Res Commun 2004; 317: 370–6
   PubMed Web of Science ®Google Scholar
• Kon S, Maeda M, Segawa T, Hagiwara Y, Horikoshi Y, Chikuma S, et al. Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms. J Cell Biochem 2000; 77: 487–98
   PubMedGoogle Scholar
• Kon S, Yokosaki Y, Maeda M, Segawa T, Horikoshi Y, Tsukagoshi H, et al. Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences. J Cell Biochem 2002; 84: 420–32
   PubMedGoogle Scholar
• Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107: 1055–61
   PubMed Web of Science ®Google Scholar
• Rudland PS, Platt-Higgins A, El-Tanani M, De Silva Rudland S, Barraclough R, Winstanley JH, et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res 2002; 62: 3417–27
   PubMedGoogle Scholar
• Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 2002; 287: 1671–9
   PubMed Web of Science ®Google Scholar
• Tuck AB, O'Malley FP, Singhal H, Harris JF, Tonkin KS, Kerkvliet N, et al. Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer 1998; 79: 502–8
   PubMed Web of Science ®Google Scholar
• Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 2001; 7: 4060–6
   PubMed Web of Science ®Google Scholar
• Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 2002; 52: 19–24
   PubMedGoogle Scholar
• Hotte SJ, Winquist EW, Stitt L, Wilson SM, Chambers AF. Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. Cancer 2002; 95: 506–12
   PubMedGoogle Scholar
• Thalmann GN, Sikes RA, Devoll RE, Kiefer JA, Markwalder R, Klima I, et al. Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 1999; 5: 2271–7
   PubMedGoogle Scholar
• Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168–70
   PubMed Web of Science ®Google Scholar
• Oh SH, Hatch HM, Petersen BE. Hepatic oval “stem” cell in liver regeneration. Semin Cell Dev Biol 2002; 13: 405–9
   PubMed Web of Science ®Google Scholar
• Matsui A, Mochida S, Ohno A, Nagoshi S, Hirose T, Fujiwara K. Plasma osteopontin levels in patients with fulminant hepatitis. Hepatol Res 2004; 29: 202–6
   PubMed Web of Science ®Google Scholar
• Wang Y, Mochida S, Kawashima R, Inao M, Matsui A, YouLuTu ZY, et al. Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acne-treated rat liver. J Gastroenterol 2000; 35: 696–701
   PubMed Web of Science ®Google Scholar
• Kawashima R, Mochida S, Matsui A, YouLuTu ZY, Ishikawa K, Toshima K, et al. Expression of osteopontin in Kupffer cells and hepatic macrophages and stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 1999; 256: 527–31
   PubMed Web of Science ®Google Scholar
• Bustos M, Sangro B, Alzuguren P, Gil AG, Ruiz J, Beraza N, et al. Liver damage using suicide genes. A model for oval cell activation. Am J Pathol 2000; 157: 549–59
   PubMedGoogle Scholar
• Akhurst B, Croager EJ, Farley-Roche CA, Ong JK, Dumble ML, Knight B, et al. A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver. Hepatology 2001; 34: 519–22
   Google Scholar
• Murakami T, Baron RL, Peterson MS. Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR findings. Radiology 1996; 198: 239–42
   PubMedGoogle Scholar
• Faris RA, Konkin T, Halpert G. Liver stem cells: a potential source of hepatocytes for the treatment of human liver disease. Artif Organs 2001; 25: 513–21
   PubMed Web of Science ®Google Scholar
• Demetris AJ, Seaberg EC, Wennerberg A, Ionellie J, Michalopoulos G. Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes. Am J Pathol 1996; 149: 439–48
   PubMedGoogle Scholar
• Roskams T, De Vos R, Desmet V. Undifferentiated progenitor cells” in focal nodular hyperplasia of the liver. Histopathology 1996; 28: 291–9
   PubMedGoogle Scholar
• Alison MR, Golding M, Sarraf CE, Edwards RJ, Lalani EN. Liver damage in the rat induces hepatocyte stem cells from biliary epithelial cells. Gastroenterology 1996; 110: 1182–90
   PubMed Web of Science ®Google Scholar
• Nambi P, Gellai M, Wu HL, Prabhakar U. Up-regulation of osteopontin in ischemia-induced renal failure in rats: a role for ET-1?. Biochem Biophys Res Commun 1997; 241: 212–4
   PubMedGoogle Scholar
• Verstrepen WA, Persy VP, Verhulst A, Dauwe S, De Broe ME. Renal osteopontin protein and mRNA up-regulation during acute nephrotoxicity in the rat. Nephrol Dial Transplant 2001; 16: 712–24
   PubMedGoogle Scholar
• Litvinov RI, Vilaire G, Shuman H, Bennett JS, Weisel JW. Quantitative analysis of platelet alpha v beta 3 binding to osteopontin using laser tweezers. J Biol Chem 2003; 278: 51285–90
   PubMed Web of Science ®Google Scholar